NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
33 hedge funds and large institutions have $6.42M invested in InVivo Therapeutics Holdings Corp in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $25K
Holders
33
Holding in Top 10
–
Calls
–
Puts
$25K
Top Buyers
| 1 | +$141K | |
| 2 | +$78K | |
| 3 | +$73K | |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$69K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$50.4K |
Top Sellers
| 1 | -$1.36M | |
| 2 | -$680K | |
| 3 | -$434K | |
| 4 |
ECM
Element Capital Management
New York
|
-$368K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$225K |